# Atropine for Preventing Ventilator-Associated Pneumonia

> **NCT02704923** · PHASE2 · COMPLETED · sponsor: **Universidade de Passo Fundo** · enrollment: 40 (actual)

## Conditions studied

- Ventilator-Associated Pneumonia

## Interventions

- **DRUG:** Atropine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02704923
- **Lead sponsor:** Universidade de Passo Fundo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704923, "Atropine for Preventing Ventilator-Associated Pneumonia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02704923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*